These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 7877320)

  • 1. Implantable cardioverter-defibrillator. Evaluation of clinical neurologic outcome and electroencephalographic changes during implantation.
    Adams DC; Heyer EJ; Emerson RG; Spotnitz HM; Delphin E; Turner C; Berman MF
    J Thorac Cardiovasc Surg; 1995 Mar; 109(3):565-73. PubMed ID: 7877320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of neuron-specific enolase and S100 after implantation of cardioverters/defibrillators.
    Dworschak M; Franz M; Czerny M; Gorlitzer M; Blaschek M; Grubhofer G; Haider W
    Crit Care Med; 2003 Aug; 31(8):2085-9. PubMed ID: 12973163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of spectral EEG changes during short periods of circulatory arrest.
    Visser GH; Wieneke GH; Van Huffelen AC; De Vries JW; Bakker PF
    J Clin Neurophysiol; 2001 Mar; 18(2):169-77. PubMed ID: 11435809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spanish implantable cardioverter-defibrillator registry. Seventh official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2010)].
    Alzueta J; Fernández JM
    Rev Esp Cardiol; 2011 Nov; 64(11):1023-34. PubMed ID: 21967881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
    O'Neill JO; Starling RC; Khaykin Y; McCarthy PM; Young JB; Hail M; Albert NM; Smedira N; Chung MK
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.
    Weiss R; Knight BP; Gold MR; Leon AR; Herre JM; Hood M; Rashtian M; Kremers M; Crozier I; Lee KL; Smith W; Burke MC
    Circulation; 2013 Aug; 128(9):944-53. PubMed ID: 23979626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of induced cardiac arrest on cognitive function after implantation of a cardioverter-defibrillator.
    da Silva MP; Rivetti LA; Mathias LA; Cagno G; Matsui C
    Rev Bras Anestesiol; 2009; 59(1):37-45. PubMed ID: 19374214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in device therapy for malignant ventricular arrhythmias.
    Horton HL; Marinchak RA; Rials SJ; Kowey PR
    Arch Intern Med; 1995 Nov; 155(21):2342-5. PubMed ID: 7487260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative electroencephalography: a method to assess cerebral injury after hypothermic circulatory arrest.
    Mezrow CK; Midulla PS; Sadeghi AM; Gandsas A; Wang W; Bodian C; Shing HH; Zappulla R; Dapunt OE; Griepp RB
    J Thorac Cardiovasc Surg; 1995 May; 109(5):925-34. PubMed ID: 7739254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cerebral perfusion during third-generation implantable cardioverter defibrillator testing.
    Singer I; Edmonds H
    Am Heart J; 1994 Apr; 127(4 Pt 2):1052-7. PubMed ID: 7909187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
    Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
    J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of repeated short episodes of circulatory arrest on cerebral function. Reassuring electroencephalographic (EEG) findings during defibrillation threshold testing at defibrillator implantation.
    Vriens EM; Bakker PF; Vries JW; Wieneke GH; Van Huffelen AC
    Electroencephalogr Clin Neurophysiol; 1996 Apr; 98(4):236-42. PubMed ID: 8641146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spanish Implantable Cardioverter-defibrillator Registry. Ninth official report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2012).
    Alzueta J; Fernández JM
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):881-93. PubMed ID: 24773996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.